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Abstract
Background: Technical advances following the Human Genome Project revealed that high-quality and -quantity
DNA may be obtained from whole saliva samples. However, usability of previously collected samples and the
effects of environmental conditions on the samples during collection have not been assessed in detail. In five
studies we document the effects of sample volume, handling and storage conditions, type of collection device,
and oral sampling location, on quantity, quality, and genetic assessment of DNA extracted from cells present in
saliva.
Methods: Saliva samples were collected from ten adults in each study. Saliva volumes from .10-1.0 ml, different
saliva collection devices, sampling locations in the mouth, room temperature storage, and multiple freeze-thaw
cycles were tested. One representative single nucleotide polymorphism (SNP) in the catechol-0-methyltransferase
gene (COMT rs4680) and one representative variable number of tandem repeats (VNTR) in the serotonin
transporter gene (5-HTTLPR: serotonin transporter linked polymorphic region) were selected for genetic analyses.
Results: The smallest tested whole saliva volume of .10 ml yielded, on average, 1.43 ± .77 μg DNA and gave
accurate genotype calls in both genetic analyses. The usage of collection devices reduced the amount of DNA
extracted from the saliva filtrates compared to the whole saliva sample, as 54-92% of the DNA was retained on the
device. An “adhered cell” extraction enabled recovery of this DNA and provided good quality and quantity DNA.
The DNA from both the saliva filtrates and the adhered cell recovery provided accurate genotype calls. The effects
of storage at room temperature (up to 5 days), repeated freeze-thaw cycles (up to 6 cycles), and oral sampling
location on DNA extraction and on genetic analysis from saliva were negligible.
Conclusions: Whole saliva samples with volumes of at least .10 ml were sufficient to extract good quality and
quantity DNA. Using 10 ng of DNA per genotyping reaction, the obtained samples can be used for more than one
hundred candidate gene assays. When saliva is collected with an absorbent device, most of the nucleic acid
content remains in the device, therefore it is advisable to collect the device separately for later genetic analyses.
Background
In the wake of the Human Genome Project, information
from GenomeWide Association (GWA) studies is accumu-
lating at a rapid rate. GWA studies include large numbers
of well-characterized cases and several hundred thousand
polymorphisms in an attempt to identify candidate genes
with plausible linkages to the phenotypes of specific interest
[1]. Once identified as biologically plausible, subsequent
studies conducted on independent populations endeavour
to replicate the genotype-phenotype association, because
confirmation of small genetic effect is crucial in complex
inheritance disorders and traits. Research groups can
potentially use already collected biological samples for
genetic analyses. In a series of studies we show that saliva
samples, even though originally not designed for genetic
analyses, can be reliably used for genotyping genetic poly-
morphisms. Recommendations are provided to guide
researchers with archived specimens, as well as those pre-
paring to launch new data collections.
In studies involving children and healthy subjects, non-
invasive sampling of DNA is preferred. Mailing buccal or
saliva samples in large-scale epidemiological studies is
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also the choice of method. Recent studies reveal that
high-quality and -quantity DNA can be obtained from
saliva samples [2-4]. However, the use of saliva as a bios-
pecimen is associated with several special issues. Depend-
ing on the method used to collect saliva, the specimen
will yield different volumes, raising the possibility that
the quantity of DNA available to be extracted will also
vary. Saliva contains a variety of compounds that have
the potential to degrade proteins and nucleic acids [5]. If
samples are stored or transported at room temperature,
the activity of these compounds or their products may
affect the DNA extracted from the sample. Even under
healthy circumstances, oral fluids contain a diverse array
of microbes (e.g., virus, bacteria, and fungi), and therefore
estimates of DNA quantity and quality in saliva may be
overestimated (or confounded) by DNA from these
microorganisms [2]. Cells may also adhere to different
devices that are utilized in saliva sample collection (e.g.,
cotton, foam, and hydrocellulose), causing lower quanti-
ties of DNA to be present in the extracted saliva speci-
men. Additionally, “saliva” is a mixture of different fluids
produced by multiple glandular sources (i.e., parotid, sub-
lingual, submandibular salivary glands). Each gland pro-
duces a different volume of saliva and secretes different
constituents, raising the possibility that specific oral fluid
types may contain more or less nucleic acid content. The
past two decades have witnessed the adoption and inte-
gration of minimally invasive measures (in saliva) in stu-
dies of the psychobiology of the stress response (e.g.,
cortisol, alpha-amylase [6]), secretory products of the
endocrine systems (e.g., testosterone [7]), inflammatory
processes (e.g., cytokines [8]), and pathogen-specific anti-
bodies (e.g., HSV [9]). Access to these tools is now wide-
spread, collection and assay protocols are being
standardized, and salivary analytes and biomarkers are
being employed across many subfields.
In a series of comparative analyses of saliva samples
collected using commonly employed techniques the
effects of saliva volume, handling, and storage conditions,
collection device, and sampling location in the mouth
were tested on the quantity and quality of extracted
DNA. We also confirmed whether the detection of repre-
sentative single nucleotide polymorphism (SNP) and vari-
able number of tandem repeats (VNTR) are affected by
these factors and processes. For the genetic analyses, two
functional polymorphisms were selected from the psy-
chogenetic literature [10]. The Val158Met (rs4680) SNP
of the catechol-0-methyltransferase (COMT) gene causes
an amino acid change from valine to methionine at the
158th position in the membrane-bound isoform. The
Met-variant results in 2 to 4 times lower enzymatic activ-
ity [11], affecting degradation of catecholamines (e.g.,
dopamine) in the central nervous system. This SNP dis-
plays a trimodal distribution of enzyme activity: low
(Met/Met), intermediate (Val/Met), and high (Val/Val)
[12]. The investigated VNTR was the so-called 5-
HTTLPR (serotonin transporter linked polymorphic
region) located in the promoter region of the serotonin
transporter gene (SLC6A4). It has two main alleles in
Caucasians: 14-repeat = Short (S) and 16-repeat = Long
(L) allele. The short variant showed reduced transcription
activity in a reporter gene system and in lymphoblasts
[13,14].
Study 1: Are the typical volumes of saliva collected in
research studies sufficient to enable isolation of DNA for
genetic analyses?
The attention saliva has received as a research and diag-
nostic specimen [15] is largely due to the perception that
sample collection is quick and uncomplicated. In many
circumstances this claim is true. However, saliva collec-
tion from infants less than 3 months of age often results
in low specimen volumes [16]. Later in early childhood
(12-18 months), saliva collection by a stranger becomes
complicated by more frequent occurrences of anxiety
and non-compliance with collection procedures [17]. On
the opposite end of the continuum, collecting saliva from
the elderly can be time-consuming and also may have a
high failure rate. Xerostomia (dry mouth) is a common
iatrogenic effect of medications, and dry mouth presents
in a high percentage of participants in studies of the old-
est-old [18]. Thus, in field settings the volume of saliva
available to be collected will vary. In Study 1, we tested
how variation in the volume of saliva collected affects the
quality and quantity of DNA, and the detection of 5-
HTTLPR and COMT Val158Met polymorphisms.
Study 2: Do collection device materials affect the
isolation of sufficient quantity and quality DNA from
saliva?
Historically, saliva collection devices involve cotton-absor-
bent materials [19]. When placed in the mouth (2-3 min),
cotton saturates with saliva which is then expressed into
collection vials by centrifugation or compression [20].
Most of the time, this approach is convenient, simple, and
time-efficient. However, when the absorbent capacity is
large and sample volume is small, the specimen absorbed
can be diffusely distributed and specimen recovery
becomes problematic [21]. Contemporary collection meth-
ods now employ synthetic or hydrocellulose rather than
cotton fibers and yield a much higher sample recovery
rate (e.g., hydrocellulose microsponge, synthetic pledget or
swab). When the participant is older than 6 years, awake,
compliant, and capable of following instructions, collecting
whole saliva by passive drool is optimal [17].
It is possible that some of the materials used to collect
saliva may bind and retain cells or nucleic acids such that
the DNA extracted from saliva using these tools would
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be compromised. In Study 2, we examined this possibility
utilizing four common saliva collection methods (1) BD
hydrocellulose microsponge, (2) Richmond cotton rope,
(3) Sarstedt synthetic pledget, and (4) Salimetrics syn-
thetic swab, and (5) passive drool as a control.
Study 3: What are the effects of storing saliva samples at
room temperature on the extraction and analysis of
DNA?
In research studies, saliva specimens are often gathered in
the field or in such conditions that restrict the way in
which they can be handled and stored. Typically, once a
specimen is collected, samples are kept cold and then fro-
zen to maintain sample integrity. Refrigeration prevents
degradation of some salivary analytes and restricts proteo-
lytic enzyme activity and bacteria growth. For large-scale
national surveys, in which investigators are working in
remote areas [22,23] or for diurnal cortisol assessment
where patients are collecting samples at home [24], freez-
ing and shipping samples frozen can be cost-prohibitive.
Appropriate sample handling after collection is essential to
maintaining sample integrity; the handling plan needs to
be worked out a priori and matched specifically to the
“needs” of the analytes to be measured. For example, sali-
vary cortisol or alpha-amylase levels were shown to be
stable at room temperature (RT) for up to 5 days [25,26].
DNA is very stable molecule; however, with respect to
extracting DNA from saliva held at RT for any length of
time, there are two issues. First, when measuring the
quantity and quality of DNA spectrophotometrically, the
measurement technique does not differentiate between
human and microbial DNA. Bacteria load and growth in
specimens held at RT raise the possibility that the amount
of microbial DNA in the extracted DNA is rising over
time in proportion to bacteria growth. Second, bacterial
DNAses can degrade human DNA, raising the possibility
that saliva samples held at RT for varying lengths of time
would yield lower quantities of human DNA suitable for
determination of polymorphisms. In Study 3, saliva sam-
ples were held at RT for up to 5 days so the effects of this
sample treatment on DNA quality, quantity, and genotyp-
ing could be observed.
Study 4: Do archived saliva samples that have been
exposed to multiple freeze-thaw cycles yield sufficient
quantity and quality DNA for genetic analyses?
Saliva samples that have already been assayed for multi-
ple analytes and archived have often been subjected to
multiple freeze-thaw cycles. Levels of certain salivary
steroid hormones (e.g., cortisol, progesterone) and pro-
tein biomarkers (e.g., alpha-amylase, immunoglobulin A)
show stability over the repeated freeze-thaw cycles in
pilot studies [25-28]. However, the extraction of DNA
from saliva may be decreased due to freeze-thaw cycle-
related damage to DNA or enhanced by the effects of
freeze-thaw cycles on the breakdown of cellular materi-
als. Therefore, saliva samples that have been archived
after multiple freeze-thaw cycles may yield different
quantity and quality DNA. In Study 4, we explore this
possibility.
Study 5: When oral fluids are collected from specific areas
in the mouth associated with different salivary glands, is
there a difference in DNA quality or quantity?
Whole saliva is a composite derived from oral fluids
secreted by many salivary glands. The largest glands are
the parotid (located upper posterior area of oral cavity),
submandibular (lower area between cheek and jaw), and
sublingual (under tongue). Some oral fluid also comes
from the serum via the crevicular fluid (area between teeth
and gums) or via mucosal damage and by leakage. Each
type of gland secretes fluid with characteristic composition
and properties [29]. The contribution each source gland
makes to the overall “oral fluid pool” is variable; conse-
quently, the composition of the saliva exhibits consider-
able variation. For instance, mucins make saliva viscous,
elastic, and sticky to protect tooth enamel against wear
and encapsulate microorganisms. These glycoproteins are
not present in oral fluid secreted by the parotid gland.
Under resting conditions, minimal fluid contribution from
the parotid gland occurs and the levels of mucins in saliva
will be high (consequentially, specimens will be more vis-
cous). However, after stimulation, saliva flow from the par-
otid gland (e.g., in response to autonomic nervous system
activation) will dilute the concentration of mucins and
specimens will be less viscous [29].
The concentration of some analytes of interest is higher
in the output of some salivary glands than others. As dif-
ferent salivary glands contribute different amounts to oral
fluids, results may differ depending on where in the
mouth samples are collected. These observations raise the
possibility that the unsystematic application of common
saliva collection techniques might cause researchers to
inadvertently sample oral fluids from different areas in the
mouth, and that this variation in oral fluid type may con-
tribute measurement error. This phenomenon seems less
problematic when the specimen collected is whole saliva
but more likely when oral fluid specimens are collected
with absorbent materials such as filter papers, micro-
sponges, or small oral swabs that may not be placed in the
same specific area in the mouth [30] consistently within
and/or across sampling occasions [31,32]. In Study 5, we
explored the contribution of oral fluid type (i.e., sampling
saliva from different locations in the mouth), to differences
in the quantity and quality of DNA extracted from those
biospecimens.
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Methods
Participants and Design
The following five studies were planned in compliance
with the guidelines of the Helsinki Declaration. The proto-
col and procedures involving healthy participants were
reviewed and approved by the Penn State University insti-
tutional review board, and informed consent was obtained
from all participants.
Study 1: Ten healthy adults donated a bolus sample (2 ×
2 ml) of whole saliva over 10 minutes. Following the
recommendations of Granger and colleagues [17], samples
were collected using the passive drool technique. Briefly,
participants were asked to imagine that they were chewing
their favourite food, move their jaws as if they were chew-
ing that food, and gently force the pooling saliva generated
through a short plastic drinking straw into a polypropylene
collection vial (2.0 ml). After collection, samples were vor-
texed (mixed) and aliquoted into separate cyrogenic sto-
rage vials in volumes of .10, .25, .50, and 1.0 ml. Samples
(n = 40) were stored frozen at -20°C until extraction and
assay.
Study 2: Ten healthy adults donated a bolus sample (5
ml) of whole saliva. After collection, samples were vor-
texed (mixed) and aliquoted into five separate 2 ml centri-
fuge tubes in volumes of .50 ml. A different collection
device (1) BD hydrocellulose microsponge (BD Medical-
Ophtalmic Systems, Waltham, MA, USA), (2) Richmond
cotton rope (Richmond Dental, Charlotte, NC, USA), (3)
Sarstedt synthetic pledget (Sarstedt AG & Co, Nümbrecht,
Germany), and (4) Salimetrics synthetic swab (Salimetrics
LLC, State College, PA, USA) was submerged into each
aliquot for 3 minutes. Saliva was expressed from the
devices by centrifugation (1500 g) for 15 min. Saliva sam-
ples (n = 50) were stored frozen at -20°C until the day of
extraction.
Study 3: Ten healthy adults donated a bolus sample
(3 ml) of whole saliva. After collection, samples were vor-
texed (mixed) and aliquoted into five separate volumes of
.50 ml. One aliquot was frozen at -20°C immediately
thereafter and served as an “untreated” control. The
remaining four aliquots were held at room temperature
(RT, 18-22°C) and frozen after 24 hrs, 48 hrs, 72 hrs, or
120 hrs (5 days). At the conclusion of the 5-day period, all
samples (n = 50) remained stored frozen at -20°C until the
day of extraction.
Study 4: Ten healthy adults donated a bolus sample
(3 ml) of whole saliva by the passive drool technique.
After collection, samples were vortexed (mixed) and ali-
quoted into five separate volumes of .50 ml in 2.0 ml
cryogenic vials. One aliquot was extracted immediately
without freezing and served as an “untreated” control.
The remaining 4 aliquots were exposed to 1, 2, 4 or 6
freeze-thaw cycles. The duration of each “freeze” cycle
was 45 min at -20°C and each “thaw” cycle was 45 min
at RT. On the final freeze-thaw cycle for each condition,
samples were left frozen at -20°C until the day of
extraction.
Study 5: Ten healthy adults first donated .50 ml of whole
saliva by the passive drool technique into a 2 ml vial.
Then, each participant placed hydrocellulose micro-
sponges (BD Medical-Ophtalmic Systems, Waltham, MA,
USA) simultaneously in three different areas of the mouth
for 5 min. Devices were placed under the tongue to absorb
oral fluid produced in the sublingual salivary gland area,
between the lower left cheek and gum to collect oral fluid
from the submandibular salivary gland area, and also
between the upper right cheek and gum in the rear of the
mouth by the jaw hinge to gather oral fluid from the paro-
tid salivary gland area. Upon removal from the mouth,
participants sealed the devices in a 2 ml cyrovial, and the
samples were stored at -80°C until assay. After a 10 min
wait period, the same participants placed 1 × 4 cm absor-
bent synthetic oral swabs (Salimetrics LLC, State College,
PA, USA) simultaneously in the three different areas of
the mouth listed above for 5 min. Upon removal, each
swab was sealed in a polypropylene carrier tube and stored
at -80°C until assay. The order of device use (i.e., micro-
sponge and then oral swab, or visa versa) was counterba-
lanced among participants. Sample volume recovery was
measured when transferring sample into extraction tube.
Saliva samples (n = 70) were stored frozen at -20°C until
the day of extraction.
DNA Extraction
A modified Puregene (Gentra) DNA isolation kit was used
for DNA extraction. On the day of extraction, all samples
were thawed and then centrifuged at 2300 g for 10 min-
utes. After centrifugation of the saliva, the top supernatant
was removed by pipette and discarded. Cell lysis was
achieved by adding 350 μl of lysate solution with .9 U pro-
teinase K to the precipitated cells (pellet). The cell lysate
was then incubated at 56°C with brief periods of mixing
for 1 hour. To precipitate proteins, the sample was cooled
to RT and 100 μl of protein precipitation solution was
added to the lysate. The mixture was placed in an ice bath
for 5 min and then centrifuged at 15,000 g for 3 min.
DNA extraction was achieved by pipetting the supernatant
into a 1.5 ml microcentrifuge tube containing 350 μl 100%
isopropanol with .10 mg glycogen. The solution was
mixed via several gentle inversions and allowed to sit
undisturbed for 5 min at RT before centrifuging it at
15,000 g for 5 min. Afterwards the supernatant was dis-
carded without disturbing the DNA-containing pellet. The
DNA pellet was washed two times in 350 μl 70% ethanol
by gently inverting the tube and centrifugation at 15,000 g
for 5 min. After the final wash, all ethanol was removed
from the sample and the DNA was allowed to dry for
15 min at RT. DNA was then dissolved by adding 50 μl
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warm TE (10 mM Tris, 1 mM EDTA) buffer (for extended
storage), and samples were stored at -20°C. DNA quality
and quantity were estimated by measuring the absorbance
of the sample at wavelengths 260 nm and 280 nm using a
spectrophotometer (NanoVue Spectrophotometer, GE
Healthcare). Nucleic acid absorbs ultraviolet light (UV)
with an absorption peak at 260 nm, whereas proteins with
aromatic side chains have an absorption peak at 280 nm.
An optical density of 1 at 260 nm corresponds to about
50 ng/μl of double-stranded DNA, whereas the 1.8 or
higher 260/280 nm ratio indicates that the DNA sample is
relatively free from protein contamination (the acceptable
range is 1.5-2.0). After the NanoVue measurements, the
DNA samples were diluted to a final concentration of
15 ± 5 ng/μl for the genetic analyses. DNA samples were
stored frozen until the day of assay.
After extracting and measuring the DNA recovered in
Study 2, it was hypothesized that a large percentage of the
samples’ nucleic acid content was retained in the absor-
bent devices. An “adhered cell” modified extraction techni-
que was developed in effort to recover the remaining DNA
in the collection devices. The “dry” collection devices,
which had been re-frozen at -20°C following the centrifu-
gation step as presented above, were then retrieved and
used for subsequent analyses. The DNA in the collection
devices was recovered by adding the 350 μl of lysate solu-
tion (with .9 U proteinase K) onto the device. After 1 hour
of incubation at 56°C the collection device was centrifuged
and the resulting filtrate solution used to complete the
extraction process, taking up the procedure at the protein
precipitation step and completing as described previously.
Genotyping 5-HTTLPR
Polymerase chain reaction (PCR) was used according to
Wendland et al. [33] with the HotStar Taq DNA-polymer-
ase kit (Qiagen) applying .25 U enzyme in a total volume
of 10 μl, and 10-20 ng genomic DNA. Thermocycling was
initiated by a 15 min 95°C denaturation step, followed by
35 cycles of 94°C 1 min, 65°C 30 sec, 72°C 1 min, and a
10 min 72°C final extension (Perkin Elmer 9700 Thermal
Cycler). The VNTR was determined by capillary electro-
phoresis using a 3130xl Genetic Analyzer to separate the
469 bp PCR product of the S allele from the 512 bp PCR
product of the L allele. To prepare for the electrophoresis
analysis, 1 μl PCR product was dissolved in formamide
loading solution with GeneScan Rox size standard in a
total volume of 10 μl and heated at 95°C for 5 min, fol-
lowed by at least 1 min at -20°C. For data analysis, Gene-
Marker® HID software was used; results are reported for
the 5-HTTLPR as S/S, S/L, and L/L genotype groups. The
genotyping procedure was carried out at the Nucleic Acid
and Protein Core Facility of the Children’s Hospital of Phi-
ladelphia Research Institute with lab staff blind to the sam-
ple data.
Genotyping COMT Val158Met
A 5’ nuclease assay was used for the COMT Val158Met
SNP (rs4680) with a pre-designed TaqMan kit
(C_25746809_50, Applied BioSystems) and 10-20 ng of
genomic DNA. The amplification conditions were: 2 min
at 50°C and 10 min at 95°C followed by 40 cycles of 15 sec
at 92°C and 90 sec at 60°C in ABI Prism® 7500 (Applied
Biosystems). Allelic discrimination analysis was performed
using the Sequence Detector Systems software; results are
reported in three COMT genotype groups: Met/Met, Val/
Met, Val/Val. The genotyping procedure was performed at
the Mitotyping Technologies Laboratory (State College,
PA) with lab staff blind to the sample descriptions.
In each study the reference genotypes of the participants
were obtained from the .50 ml whole saliva samples col-
lected by the passive drool technique and stored under the
control condition, i.e., frozen within half an hour of the
collection and thawed only once on the day of DNA
extraction.
Results and Discussion
Study 1
In the first study comparing different volume of whole sal-
iva one-way repeated measure ANOVAs were computed
with sample volume (.10, .25, .50, and 1.0 ml) as a 4-level
independent variable. DNA concentration (ng/μl) and the
260/280 nm ratio were the dependent measures. An out-
lier greater than 3 SD from the mean was removed from
the 1.0 ml condition. Table 1 contains the means and stan-
dard deviations for the DNA quantity and quality at each
sample volume. A linear contrast was computed followed
by a priori comparisons (t-tests) to decompose the nature
of the effect of sample volume.
DNA Quantity and Quality
Results revealed significant effects of sample volume on
DNA quantity, F (3, 24) = 31.36, p <.001. The linear con-
trast was significant, F (1, 9) = 7.02, p < .05. A priori com-
parisons (t-tests, one-tailed) revealed that DNA
concentration was lower in the .10 ml sample than in the
.25 ml sample, t (9) = 4.99, p < .001; lower in the .25 ml
sample than in the .50 ml sample, t (9) = 3.42, p < .01; and
lower in the .50 ml sample than in 1.0 ml, t (8) = 6.45, p <
.001. By contrast, the main effect of volume on DNA qual-
ity was not significant, F (3, 24) = 1.58, ns. As can be seen
in Table 1, even with only .10 ml of whole saliva in the
specimen, on average, the DNA extracted exceeded 20 ng/
μl concentration (1 μg amount) and the quality of the spe-
cimen was acceptable.
Genotyping
Among the 10 subjects, all 3 genotypes were represented
at both polymorphisms: COMT Met/Met (n = 3), Val/
Met (n = 5), Val/Val (n = 2); 5-HTTLPR S/S (n = 1), S/L
(n = 6), L/L (n = 3). At the COMT SNP, the genotyping
success rate of the first run (using 10-20 ng DNA) were
Nemoda et al. BMC Medical Research Methodology 2011, 11:170
http://www.biomedcentral.com/1471-2288/11/170
Page 5 of 13
the following: all samples from the .10 ml and 1.0 ml
conditions, 8/10 of the .25 ml samples, and 9/10 of the
.50 ml samples were genotyped successfully in the first
run. The 3 samples which needed repetition were suc-
cessfully genotyped in the second run using 40-60 ng
DNA. For 5-HTTLPR, the rate of successful identifica-
tion was 100% in the first genotyping run.
Whole saliva samples with volumes of at least 100 μl
were sufficient to extract good quantity and quality DNA
to make accurate determinations of genotypes for repre-
sentative SNP and VNTR polymorphisms. Based on sensi-
tive genotyping methods using 10 ng DNA per
polymorphism, the DNA samples obtained from 100 μl of
whole saliva are sufficient - on average - for genotyping
more than 100 candidate polymorphisms. However, we
have to note that the lowest DNA concentration was 9.9
ng/μl (total DNA amount .50 μg) among the 100 μl sam-
ples, hence this sample can be used only for 25-50 geno-
typing reactions. The total DNA amount isolated from at
least 250 μl of whole saliva can be sufficient for whole gen-
ome analyses requiring 1.5-3 μg DNA. However, because
of the variance among samples (the mean DNA amount
was 3.4 μg at the 250 μl samples, but ranging from .9 μg
to 7.4 μg), we suggest to collect at least 500 μl (.50 ml) of
whole saliva for GWA studies (the mean DNA amount
was 6.2 μg at the 500 μl samples, ranging from 1.5 μg to
12.4 μg).
Study 2
In the second study assessing the effects of different col-
lection devices the volume recoveries - as measured when
transferring the saliva filtrate to the extraction tube - were,
on average, .36 ml (SD = .03) for hydrocellulose micro-
sponge, .35 ml (SD = .03) for the cotton rope, .39 ml
(SD = .12) for the synthetic pledget; and .42 ml (SD = .02)
for the synthetic swab. One-way repeated measure ANO-
VAs were computed with collection device type as a
5-level independent variable separately for DNA concen-
tration (ng/μl) and 260/280 nm ratio. Planned a priori
comparisons (t-tests) tested the difference between whole
saliva (control) and each individual device.
DNA Quantity
There was a main effect of collection device/method on
DNA concentration, F (4, 36) = 15.83, p < .0001. On
average, the concentration of DNA extracted from
whole saliva (M = 256.2 ng/μl, SD = 188.24) was signifi-
cantly higher than the average level extracted from sal-
iva collected with the microsponge (M = 10.30 ng/μl,
SD = 6.11), t (9) = 4.17, p < .01; than the cotton rope
(M = 8.35 ng/μl, SD = 3.62), t (9) = 4.21, p < .01; than
the pledget (M = 12.80 ng/μl, SD = 7.94), t (9) = 4.23,
p < . 01; and the synthetic swab (M = 53.41 ng/μl, SD =
49.20), t (9) = 3.47, p < .01. The levels obtained among
the specific absorbent devices (hydrocellulose micro-
sponge, cotton rope, pledget, and synthetic swabs) did
not significantly differ from one another. Also, there
was no evidence that sample volume recovered from the
devices was associated with the concentration of the
DNA extracted.
DNA Quality
In the saliva filtrate there was also a main effect on the
260/280 nm ratio, F (4,36) = 7.02, p < .0001. The average
260/280 nm ratio in sample extracted from whole saliva
(M = 1.75, SD = .16) was significantly higher than from
the hydrocellulose microsponge filtrate (M = 1.60, SD =
.17), t (9) = 3.50, p < .01. The pledget filtrate yielded the
highest quality DNA (M = 1.88, SD = .09, t (9) = -2.20, ns),
whereas the average 260/280 nm ratio of filtrates from
cotton rope (M = 1.69, SD = .11, t (9) = .96, ns) and syn-
thetic swab (M = 1.72, SD = .16, t (9) = 1.63, ns) were
similar to that of the whole saliva.
Genotyping
Genotype groupings at the two polymorphisms were:
COMT: Val/Met (n = 6), Val/Val (n = 4); 5-HTTLPR:
S/S (n = 3), S/L (n = 4), L/L (n = 3). Despite the sig-
nificant differences in DNA quantity by collection
method, there was 100% accuracy in the determination
of COMT Val158Met polymorphism within each sub-
ject across collection device type, and there was only
one misgenotyping at the 5-HTTLPR (S/L instead of
L/L). All samples except one from the pledget filtrates
yielded good genotype calls in the first genotyping run
at the COMT SNP; the sample which needed repeti-
tion was successfully genotyped in the second run. For
5-HTTLPR, the genotyping success rate of the first
genotyping run was 100% for whole saliva, cotton rope
and pledget filtrate samples. There was one non-deter-
mination for the microsponge filtrates, and the
Table 1 Study 1: Means (Standard Deviations) of DNA sample characteristics isolated from different volumes of whole
saliva
Sample Volume
.10 ml .25 ml .50 ml 1.0 ml
DNA Concentration (ng/μl) 28.25 (15.36) 68.00 (39.66) 116.90 (55.19) 239.78 (144.27)
DNA Quality (260/280 nm) 1.78 (.10) 1.75 (.10) 1.74 (.14) 1.79 (.11)
DNA Total Amount (μg) 1.43 (.77) 3.40 (1.98) 6.24 (3.38) 11.99 (5.71)
Note: At the end of DNA isolation all samples were dissolved in 50 μl final volume, and 2 μl of these samples were used for DNA concentration and 260/280 nm
ratio measurements by NanoVue Spectrophotometer. For a better comparison with other studies, the total amount of DNA is also provided in the table.
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misgenotyping mentioned above occurred with one of
the synthetic swab filtrates.
As can be seen in Table 2, after extracting DNA from
the saliva passed through the devices (i.e., the saliva fil-
trate), the quantity of DNA recovered was very low com-
pared to the whole saliva sample control. The “adhered
cell” hypothesis was confirmed by the results of the modi-
fied extraction, as the quantity and quality of the DNA
samples extracted from the adhered cells were comparable
to that of the whole saliva samples (Table 2). More nota-
bly, all of these samples could be accurately genotyped for
the COMT SNP in the first genotyping run. For each spe-
cimen, a percentage of DNA extracted from the collection
device (i.e., adhered cell) was computed. On average, the
percentage of DNA retained in each device was 91.34% for
the hydrocellulose microsponge, 92.32% for the cotton
rope, 86.74% for the pledget, and 53.91% for the synthetic
swab. Table 2 presents the descriptive data for the DNA
extracted via the Saliva Filtrate and Adhered Cell
procedures.
When saliva is collected using absorbent devices, a con-
siderable portion of the nucleic acid content is retained in
the absorbent devices. The DNA retained in collection
devices studied here can be obtained using a secondary
extraction protocol. Despite this phenomenon, DNA
extracted from saliva filtrate was sufficient to accurately
call the COMT Val158Met polymorphism in every condi-
tion, and detection of the 5-HTTLPR in almost every
condition.
Study 3
In the third study analyzing the effect of room tempera-
ture storage one-way repeated measure ANOVAs were
computed with time stored at RT prior to freezing as a 5-
level independent variable separately for DNA concentra-
tion and 260/280 nm ratio. A planned comparison tested
the linear effect of time, and a priori contrasts (t-tests)
compared the control condition (frozen immediately) to
each individual time point (24, 48, 72, and 120 hrs).
DNA Quantity and Quality
The main effect of storage at RT on DNA concentration
was not significant, F (4, 36) = .94, ns. By contrast, there
was a significant main effect of time at RT on the 260/280
nm ratio, F (4, 36) = 11.40, p < .0001 (see Figure 1).
On average, the control condition (frozen immediately, no
storage at RT) had a lower 260/280 nm ratio (M = 1.61,
SD = .19) than samples stored at RT for 24 hrs (M = 1.78,
SD = .07), 48 hrs (M = 1.82, SD = .09), 72 hrs (M = 1.89,
SD = .17), or 120 hrs (M = 1.86, SD = .09), ts (9) = 3.34 to
4.08, ps < .01. The linear contrast was significant, F (1, 9)
= 16.59, p < .01, indicating that as hours at RT increased,
the 260/280 nm ratio tended to increase. A priori compari-
sons (t-tests, one-tailed) revealed the RT-related increases
in the 260/280 nm ratio were more pronounced between
the control and 24 hrs, (t (9) = 3.33, p < .01), and between
the 24 hrs and 48 hrs, (t (9) = 2.15, p < .05) time points,
and less pronounced between the 48 hrs to 72 hrs (t (9) =
1.93, p < .05), and between 72 hrs to 120 hrs (t (9) = 1.01,
ns) intervals.
Genotyping
The genotypes at the studied polymorphisms were:
COMT Met/Met (n = 2), Val/Met (n = 5), Val/Val (n = 3);
5-HTTLPR S/S (n = 1), S/L (n = 5), L/L (n = 4). The geno-
typing success rate of the first run was 100% for the
5-HTTLPR, whereas 7 samples out of the 50 needed repe-
tition at the COMT SNP (successfully determined sample
ratios in the first genotyping run were: frozen immediately:
8/10; frozen 24 hrs: 8/10; frozen 48 hrs: 8/10; frozen
72 hrs: 10/10; frozen 120 hrs: 9/10). All samples yielded
accurate genotype calls in the second run.
Consistent with the literature documenting the stability
of nucleic acids, we observed that saliva samples could be
held at RT for many days without compromising the
usability to analyze candidate gene polymorphisms. Sto-
rage of saliva samples at RT prior to freezing, similar to
sending samples through the mail unrefrigerated, for up to
5 days did not influence the accuracy of COMT Val158-
Met or 5-HTTLPR genotyping. The success rate of the
first genotyping run was not associated with the time sam-
ples were held at RT, and probably reflects technical issues
(e.g., pipetting problem at the PCR).
Study 4
In the fourth study assessing the effect of multiple
freeze-thaw cycles one-way repeated measure ANOVAs
were computed with number of freeze-thaw cycles as a
Table 2 Study 2: Means (Standard Deviations) of DNA sample characteristics obtained comparing different collection
devices and passive drool (control)
Device Type: Microsponge Cotton Rope Synthetic Swab Pledget Passive
SF AC SF AC SF AC SF AC Drool
DNA Concentration (ng/μl) 10.30 176.20 8.35 155.35 53.41 65.38 12.28 125.70 262.68
(6.11) (107.03) (3.62) (104.60) (49.20) (43.56) (7.94) (122.68) (179.00)
DNA Quality (260/280 nm) 1.60 1.93 1.69 1.87 1.72 1.90 1.88 1.84 1.75
(.17) (.17) (.11) (.14) (.16) (.14) (.09) (.21) (.16)
Note: SF = Saliva Filtrate; AC = Adhered Cell; Passive Drool = .50 ml of whole saliva.
Nemoda et al. BMC Medical Research Methodology 2011, 11:170
http://www.biomedcentral.com/1471-2288/11/170
Page 7 of 13
5-level independent variable separately for DNA concen-
tration and 260/280 nm ratio. A planned comparison
tested the linear effect, and a priori comparisons
(t-tests) compared the no freeze-thaw cycle condition to
each exposure condition (1, 2, 4, and 6 freeze-thaw
cycles).
DNA Quantity and Quality
Freeze-thaw conditions had a main effect on both DNA
concentration, F (4, 36) = 2.86, p < .05 and DNA quality, F
(4, 36) = 3.30, p < .05. However, the linear contrast for
DNA quantity was not significant; the main difference
came from the lower DNA concentration of the extracted
immediately samples compared to the samples exposed to
one or two freeze-thaw cycles (but not to the 4 or 6
freeze-thaw cycles samples, see Figure 2A). In terms of
DNA quality, the linear contrast was significant, F (1, 9) =
5.39, p < .05. On average, the 260/280 nm ratio was com-
parable in samples extracted immediately without a
freeze-thaw cycle (M = 1.54, SD = .42), and in samples
exposed to a single freeze-thaw cycle (M = 1.67, SD = .14),
t (9) = 1.13, ns. Samples with one or fewer freeze-thaw
cycle exposure yielded lower 260/280 nm ratio on average
(M = 1.61, SD = .25) than samples exposed to 2 or more
freeze-thaw cycles (M = 1.79, SD = .07), t (9) = 2.47, p <
.05. DNA quality was not statistically different in samples
exposed to 2, 4, or 6 freeze-thaw cycles (see Figure 2B).
Genotyping
All 3 genotypes were represented at both polymorphisms:
COMT Met/Met (n = 1), Val/Met (n = 6), Val/Val (n = 3);
5-HTTLPR S/S (n = 5), S/L (n = 3), L/L (n = 2). The
determination of 5-HTTLPR and COMT Val158Met poly-
morphism was not affected by the number of freeze-thaw
Figure 1 Study 3 “Time Left at Room Temperature” concentration (Figure 1A) and quality (Figure 1B) measures of salivary DNA
obtained from passive drool. Saliva samples left out at room temperature for 0, 24, 48, 72, and 120 hours. Note: .50 ml of whole saliva was
used in each condition. Error bars represent the standard error.
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cycles or by the 260/280 nm ratio values; all samples from
the same individual gave identical results. The genotyping
success rate of the first run was 100% at the 5-HTTLPR,
whereas 6 samples out of the 50 needed repetition at the
COMT SNP (all the control, 4 and 6 freeze-thaw cycle
samples gave good quality signals in the first run but 30%
of the 1 and the 2 freeze-thaw cycle samples did not, these
samples were successfully genotyped in the second run).
The effects of freeze-thaw cycles on saliva samples were
more pronounced for the quality of DNA extracted from
archived specimens. On average, the ratio of DNA to large
molecule contaminants was enhanced by freezing and
thawing the sample. The lower 260/280 nm ratio and the
lower DNA yield of the samples extracted immediately
compared to that of the frozen samples were probably due
to the pellet formation after centrifugation, because many
times the pellets in unfrozen saliva were very loose, and
the supernatant was very viscous and thick. As a result of
incomplete separation during centrifugation, some of the
cell fraction from the unfrozen samples was lost when the
samples were decanted. However, the results of the genetic
analyses were unaffected (all the extracted immediately
samples were genotyped successfully in the first run).
Overall, neither the quantity of DNA extracted nor the
genotype determinations were systematically influenced by
exposure to freeze-thaw conditions.
Study 5
In the last study comparing sampling locations in the
mouth the volume recoveries for the microsponge condi-
tion were, on average: sublingual .26 ml (SD = .08), parotid
.19 ml (SD = .11), and submandibular .16 ml (SD = .13).
For the synthetic swab volume recoveries were, on aver-
age: sublingual .92 ml (SD = .47), parotid .49 ml (SD =
.27), and submandibular .67 ml (SD = .44). A series of 2
(hydrocellulose microsponge vs. synthetic swab) by 3
(sampling location: sublingual, parotid, submandibular)
repeated measures ANOVAs were computed separately
for DNA concentration and the 260/280 nm ratio.
DNA Quantity and Quality
The effect of device type on DNA concentration of the sal-
iva filtrates was not significant, F (1, 9) = 3.64, ns, but
there was a main effect of device type on DNA quality,
F (1, 9) = 6.85, p < .05 (Figure 3). Given the findings for
Study 2, this redundant observation is not described in
any further detail.
Genotyping
All 3 genotypes were represented at both polymorphisms:
COMT Met/Met (n = 2), Val/Met (n = 4), Val/Val (n = 4);
5-HTTLPR S/S (n = 2), S/L (n = 5), L/L (n = 3). The geno-
typing success rate was 98.6% for both polymorphisms,
with one sample out of 70 giving no result.
The findings of collection device effectiveness at differ-
ent selected oral sampling locales are consistent with the
findings in Study 2 regarding collection devices. That is,
Study 5 confirms that the synthetic swab gives a greater
recovery of DNA from the saliva filtrate than the micro-
sponge. This could be directly related to the fact that the
synthetic swab collects a larger amount of oral fluid
which can then be used for extraction. The collection
devices for Study 5 were not extracted using the “adhered
cell” extraction developed for Study 2 due to the similar-
ity of the observations for the initial extraction noted. As
expected, oral sampling location does not significantly
affect the quantity or quality of DNA recovered (per each
device evaluated). As in the previous studies, the quantity
of DNA which was recovered is still sufficient to perform
multiple genotyping procedures. Genotyping of both the
COMT rs4680 and 5-HTTLPR VNTR polymorphisms
was unaffected by the study conditions.
Conclusions
To summarize, these experiments revealed several note-
worthy findings. First, whole saliva samples with volumes
of at least 100 μl were sufficient to extract good quality
and quantity DNA. Second, when saliva is collected via
absorbent devices, the majority of the nucleic acid content
remains in the device and is not expressed in the saliva fil-
trate. It is important to note that the nucleic acid retained
in these devices can be recovered with a follow-up extrac-
tion procedure. Third, the effects of saliva storage at room
temperature (for up to 5 days), repeated freeze-thaw cycles
(up to 6 cycles), and sampling different oral fluid types on
DNA extraction from saliva were negligible. Finally, across
the conditions studied, the DNA extracted from saliva
samples was sufficient to consistently determine genotypes
for representative SNP (COMT Val158Met) and VNTR
(5-HTTLPR) polymorphisms. Since PCR-based candidate
gene analyses usually require 5-10 ng of DNA per poly-
morphism, the lowest DNA concentration samples could
be still used for determination of 20-50 polymorphisms.
Collectively, these observations serve to raise awareness in
the scientific community that a number of genetic poly-
morphisms can be determined from saliva specimens that
have already been assayed and stored at -20 or -80°C. To
do so, of course, would require appropriate ethical review
and approval. Also, the cell pellet of the same saliva sam-
ple can be used for genetic analyses in parallel to salivary
biomarker analysis conducted from the supernatant, redu-
cing the cost and time of collecting biological specimen
from the study participants.
Our main goal was to show that sufficient amount of
DNA can be obtained from saliva samples without
immediate addition of cell lysis buffer, which is used by
the most widespread saliva DNA collection techniques,
opening up the possibilities to use saliva samples for
genetic analyses without interfering with hormone, cyto-
kine or other biomarker analyses. When comparing the
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average amount of DNA per 1 ml saliva calculated from
the samples we stored under the control condition (i.e.,
frozen within half an hour of the collection) to published
data of other research groups using whole saliva mixed
with cell lysis buffer at the time of collection, our results
(ranging from 11.99 μg/ml to 26.67 μg/ml) represented
the lower end of the range, as the reported average DNA
amounts in pilot studies vary from 11.4 μg/ml [2] to 77.4
Figure 2 Study 4 “Freeze-Thaw Effects” concentration (Figure 2A) and quality (Figure 2B) measures of salivary DNA obtained from
passive drool. Saliva samples exposed to 0, 1, 2, 4, and 6 freeze-thaw cycles. Note: .50 ml of whole saliva was used in each condition. Error bars
represent the standard error.
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μg/ml [3], whereas in large scale studies the calculated
total DNA per 1 ml saliva is between 23-42 μg/ml
[4,34,35]. It is interesting to note that the total amount of
DNA obtained from saliva samples shows huge variability
both under experimental laboratory settings (e.g., 155 ±
103 μg per 2 ml saliva [3]) and in epidemiological studies
(e.g., 92 ± 74 μg per 4 ml saliva from a sample of 555
adults [34]).
Figure 3 Study 5 “Sampling Location” concentration (Figure 3A) and quality (Figure 3B) measures of salivary DNA collected from
three oral locales. Saliva samples collected from sublingual, submandibular, and parotid oral glands using hydrocellulose microsponge and
synthetic swab collection devices. Error bars represent the standard error.
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Investigators interested in the possibility of including
DNA analyses in current or future projects, who are
using absorbent materials (sponges, pledgets, swabs,
ropes) to collect saliva specimens, should be warned that
they are discarding the majority of the cells needed to
extract nucleic acids when they remove the saliva filtrate
and discard the collection device into biohazard waste.
Given the expense of sample collection, particularly in
high-risk or special populations, investigators may wish
to consider storing the collection devices (and the cell
fraction contained therein) to extract DNA from it.
Researchers should be pleased to know that DNA can
be obtained from simple and cost-effective collection
techniques already employed in the field. That is, even if
specimens have not been obtained using devices specific
for the collection, stabilization, and transportation of
DNA, they can be still used for determination of candi-
date gene polymorphisms using sensitive genotyping
methods. Sufficient quality and quantity DNA can be
recovered even from very small samples of saliva, despite
thawing and refreezing as part of testing for other ana-
lytes, and even if they have been shipped or stored unre-
frigerated for (up to 5) days. The success rates of the first
genotyping rounds (using 10-20 ng DNA) were 94-98%
across the studies at the two representative candidate
polymorphisms, with only one sample out of the 260 giv-
ing no results at either polymorphisms, suggesting that
the DNA isolation was unsuccessful only in .38% of sam-
ples. All samples retested with higher amounts of DNA
(40-60 ng) could be genotyped with repeated measure-
ments (see results for COMT SNP), hence the final suc-
cess rate reached 99.6%.
This series of studies has several methodological
strengths which lead us to have confidence in the conclu-
sions reached. However, it is important to note that the
conditions under which these specimens were collected
are different from the field conditions in which actual
specimens would be collected. Therefore, the findings
illustrate potential, rather than actual, pitfalls and pro-
blems that might be associated with extracting DNA
from saliva. Studies in field settings aimed to corroborate
these results would be a worthwhile next step. Another
important limitation of this study is that only spectro-
photometric measurement was used to determine DNA
concentration, preventing differentiation between human
and bacterial DNA. Therefore, the DNA concentration
values of samples left out at room temperatures for days
probably do not reflect the true amounts of human DNA.
However, the genetic analyses of these (probably con-
taminated) samples yielded the same genotypes as those
of the control samples (frozen immediately), suggesting
that sensitive PCR-methods using human specific pri-
mers and/or probes are able to detect human genetic var-
iations accurately even from a small fraction of human
DNA. Also, we limited our scope to a single representa-
tive SNP and VNTR. Future studies should consider
expanding the range of candidate polymorphisms to eval-
uate the breadth of these observations.
In this decade, an initiative led by the U.S. National
Institute of Craniofacial and Dental Research (NICDR)
characterized the salivary proteome. This ground-break-
ing effort revealed that as many as 2,000 analytes of
potential interest to the behavioral, health, sports, and
developmental sciences are present in oral fluids [36].
This library of potential salivary analytes in combination
with genetic polymorphisms, offer scientists an opportu-
nity to take the lead by testing models that involve
multi-level components of biological systems and their
relationship to behavior, health, and social forces. As
with all major developments, however, many questions
remain unanswered and specialized issues exist that
require empirical attention. Drawing attention to these
issues will increase the probability that DNA, in combi-
nation with other salivary analytes, will be more success-
fully integrated into the next generation of studies, and
in doing so, will set a more solid foundation for the
eventual translation of the basic findings into screening,
prevention, clinical investigation, and diagnostics.
Acknowledgements
Thanks are due to Becky Zavacky and Jennifer Jewell for technical assistance.
Author details
1Department of Medical Chemistry, Molecular Biology and
Pathobiochemistry, Semmelweis University, Tuzolto utca, Budapest, Hungary.
2Salimetrics LLC, Innovation Boulevard, State College, Pennsylvania, USA.
3Department of Human Development and Family Studies and Biobehavioral
Health, Pennsylvania State University, Henderson South, University Park,
Pennsylvania, USA. 4Center for Interdisciplinary Salivary Bioscience Research,
Johns Hopkins University School of Nursing and Bloomberg School of Public
Health, Baltimore, Maryland, USA.
Authors’ contributions
ZN participated in data interpretation and manuscript preparation. MG
participated in study design and results evaluation. CF performed the
statistical analysis. EB participated in study design, graphing, and data work.
JS carried out sample collection, treatment, DNA extraction and sample
preparation for polymorphism analysis; and participated in results evaluation.
DG conceived the study, and participated in project and statistical design,
write-up, and coordination. All authors participated in writing and critical
review of the manuscript. The final manuscript was approved by all authors.
Competing interests
The studies reported in this paper were conducted while Dr. Granger was
on the Faculty in the Department of Biobehavioral Health at Penn State
University. In the interest of full disclosure, Douglas A. Granger is Chief
Scientific and Strategy Advisor at Salimetrics LLC (State College, PA, USA)
and this relationship is managed by the policies of the conflict of interest
committee at the Johns Hopkins University School of Medicine.
Received: 16 June 2011 Accepted: 19 December 2011
Published: 19 December 2011
References
1. Psychiatric GWAS Consortium Coordinating Committee, Cichon S,
Craddock N, Daly M, Faraone SV, Gejman PV, et al: Genomewide
Nemoda et al. BMC Medical Research Methodology 2011, 11:170
http://www.biomedcentral.com/1471-2288/11/170
Page 12 of 13
association studies: history, rationale, and prospects for psychiatric
disorders. Am J Psychiatry 2009, 166:540-556.
2. Quinque D, Kittler R, Kayser M, Stoneking M, Nasidze I: Evaluation of saliva
as a source of human DNA for population and association studies. Anal
Biochem 2006, 353:272-277.
3. Rogers NL, Cole SA, Lan HC, Crossa A, Demerath EW: New saliva DNA
collection method compared to buccal cell collection techniques for
epidemiological studies. Am J Hum Biol 2007, 19:319-326.
4. Koni AC, Scott RA, Wang G, Bailey ME, Peplies J, Bammann K, et al: DNA
yield and quality of saliva samples and suitability for large-scale
epidemiological studies in children. Int J Obes (Lond) 2011, 35:S113-118.
5. Ochert AS, Boulter AW, Birnbaum W, Johnson NW, Teo CG: Inhibitory
effect of salivary fluids on PCR: potency and removal. PCR Methods Appl
1994, 3:365-368.
6. Rudolph KD, Troop-Gordon W, Granger DA: Peer victimization and
aggression: moderation by individual differences in salivary cortisol and
alpha-amylase. J Abnorm Child Psychol 2010, 38:843-856.
7. Booth A, Johnson DR, Granger DA, Crouter AC, McHale S: Testosterone and
child and adolescent adjustment: the moderating role of parent-child
relationships. Dev Psychol 2003, 39:85-98.
8. El-Sheikh M, Buckhalt JA, Granger DA, Erath SA, Acebo C: The association
between children’s sleep disruption and salivary interleukin-6. J Sleep Res
2007, 16:188-197.
9. Shirtcliff EA, Coe CL, Pollak SD: Early childhood stress is associated with
elevated antibody levels to herpes simplex virus type 1. Proc Natl Acad
Sci USA 2009, 106:2963-2967.
10. D’Souza UM, Craig IW: Functional genetic polymorphisms in serotonin
and dopamine gene systems and their significance in behavioural
disorders. Prog Brain Res 2008, 172:73-98.
11. Lachman HM, Papolos DF, Saito T, Yu YM, Szumlanski CL,
Weinshilboum RM: Human catechol-O-methyltransferase
pharmacogenetics: description of a functional polymorphism and its
potential application to neuropsychiatric disorders. Pharmacogenetics
1996, 6:243-250.
12. Chen J, Lipska BK, Halim N, Ma QD, Matsumoto M, Melhem S, et al:
Functional analysis of genetic variation in catechol-O-methyltransferase
(COMT): effects on mRNA, protein, and enzyme activity in postmortem
human brain. Am J Hum Genet 2004, 75:807-821.
13. Lesch KP, Bengel D, Heils A, Sabol SZ, Greenberg BD, Petri S, et al:
Association of anxiety-related traits with a polymorphism in the
serotonin transporter gene regulatory region. Science 1996,
274:1527-1531.
14. Heils A, Mossner R, Lesch KP: The human serotonin transporter gene
polymorphism–basic research and clinical implications. J Neural Transm
1997, 104:1005-1014.
15. Nieuw Amerongen AV, Ligtenberg AJ, Veerman EC: Implications for
diagnostics in the biochemistry and physiology of saliva. Ann N Y Acad
Sci 2007, 1098:1-6.
16. Herrington CJ, Olomu IN, Geller SM: Salivary cortisol as indicators of pain
in preterm infants: a pilot study. Clin Nurs Res 2004, 13:53-68.
17. Granger DA, Kivlighan KT, Fortunato C, Harmon AG, Hibel LC, Schwartz EB,
et al: Integration of salivary biomarkers into developmental and
behaviorally-oriented research: problems and solutions for collecting
specimens. Physiol Behav 2007, 92:583-590.
18. Hodgson N, Freedman VA, Granger DA, Erno A: Biobehavioral correlates of
relocation in the frail elderly: salivary cortisol, affect, and cognitive
function. J Am Geriatr Soc 2004, 52:1856-1862.
19. Dabbs JM Jr: Salivary testosterone measurements: collecting, storing, and
mailing saliva samples. Physiol Behav 1991, 49:815-817.
20. Gunnar MR, Mangelsdorf S, Larson M, Hertsgaard L: Attachment,
temperament, and adrenocortical activity in infancy: A study of
psychoendocrine regulation. Dev Psychol 1989, 25:355-363.
21. Harmon AG, Hibel LC, Rumyantseva O, Granger DA: Measuring salivary
cortisol in studies of child development: watch out–what goes in may
not come out of saliva collection devices. Dev Psychobiol 2007,
49:495-500.
22. Beall CM, Worthman CM, Stallings J, Strohl KP, Brittenham GM, Barragan M:
Salivary testosterone concentration of Aymara men native to 3600 m.
Ann Hum Biol 1992, 19:67-78.
23. Flinn MV, England BG: Social economics of childhood glucocorticoid
stress response and health. Am J Phys Anthropol 1997, 102:33-53.
24. Raff H, Homar PJ, Skoner DP: New enzyme immunoassay for salivary
cortisol. Clin Chem 2003, 49:203-204.
25. Gröschl M, Wagner R, Rauh M, Dörr HG: Stability of salivary steroids: the
influences of storage, food and dental care. Steroids 2001, 66:737-741.
26. O’Donnell K, Kammerer M, O’Reilly R, Taylor A, Glover V: Salivary alpha-
amylase stability, diurnal profile and lack of response to the cold hand
test in young women. Stress 2009, 12:549-554.
27. Garde AH, Hansen AM: Long-term stability of salivary cortisol. Scand J Clin
Lab Invest 2005, 65:433-436.
28. Booth CK, Dwyer DB, Pacque PF, Ball MJ: Measurement of
immunoglobulin A in saliva by particle-enhanced nephelometric
immunoassay: sample collection, limits of quantitation, precision,
stability and reference range. Ann Clin Biochem 2009, 46:401-406.
29. Veerman EC, van den Keybus PA, Vissink A, Nieuw Amerongen AV: Human
glandular salivas: their separate collection and analysis. Eur J Oral Sci
1996, 104:346-352.
30. de Weerth C, Jansen J, Vos MH, Maitimu I, Lentjes EG: A new device for
collecting saliva for cortisol determination. Psychoneuroendocrinology
2007, 32:1144-1148.
31. Beltzer EK, Fortunato CK, Guaderrama MM, Peckins MK, Garramone BM,
Granger DA: Salivary flow and alpha-amylase: collection technique,
duration, and oral fluid type. Physiol Behav 2010, 101:289-296.
32. Harmon AG, Towe-Goodman NR, Fortunato CK, Granger DA: Differences in
saliva collection location and disparities in baseline and diurnal rhythms
of alpha-amylase: a preliminary note of caution. Horm Behav 2008,
54:592-596.
33. Wendland JR, Martin BJ, Kruse MR, Lesch KP, Murphy DL: Simultaneous
genotyping of four functional loci of human SLC6A4, with a reappraisal
of 5-HTTLPR and rs25531. Mol Psychiatry 2006, 11:224-226.
34. Philibert RA, Zadorozhnyaya O, Beach SR, Brody GH: Comparison of the
genotyping results using DNA obtained from blood and saliva. Psychiatr
Genet 2008, 18:275-281.
35. Nishita DM, Jack LM, McElroy M, McClure JB, Richards J, Swan GE,
Bergen AW: Clinical trial participant characteristics and saliva and DNA
metrics. BMC Med Res Methodol 2009, 9:71.
36. Wong D: Salivary Diagnostics Hoboken: Wiley-Blackwell; 2008.
Pre-publication history
The pre-publication history for this paper can be accessed here:
http://www.biomedcentral.com/1471-2288/11/170/prepub
doi:10.1186/1471-2288-11-170
Cite this article as: Nemoda et al.: Assessing genetic polymorphisms
using DNA extracted from cells present in saliva samples. BMC Medical
Research Methodology 2011 11:170.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color figure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Nemoda et al. BMC Medical Research Methodology 2011, 11:170
http://www.biomedcentral.com/1471-2288/11/170
Page 13 of 13
